146 related articles for article (PubMed ID: 38564194)
21. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
[TBL] [Abstract][Full Text] [Related]
22. RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
Chen Y; Tang R; Xiong W; Zhang F; Wang N; Xie B; Cao J; Chen Z; Ma C
J Transl Med; 2023 Jun; 21(1):396. PubMed ID: 37331977
[TBL] [Abstract][Full Text] [Related]
23. IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.
Wu P; Lin B; Huang S; Meng J; Zhang F; Zhou M; Hei X; Ke Y; Yang H; Huang D
Front Endocrinol (Lausanne); 2022; 13():846106. PubMed ID: 35273577
[TBL] [Abstract][Full Text] [Related]
24. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
25. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
26. Correlation between thyroidal and peripheral blood total T cells, CD8
Al-Ansari F; Lahooti H; Stokes L; Edirimanne S; Wall J
Endocr Res; 2018 Nov; 43(4):264-274. PubMed ID: 29787340
[TBL] [Abstract][Full Text] [Related]
27. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Mazzi B; Latrofa F; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2001 Feb; 11(2):177-85. PubMed ID: 11288989
[TBL] [Abstract][Full Text] [Related]
28. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR
Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780
[TBL] [Abstract][Full Text] [Related]
29. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
30. The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves' Ophthalmopathy.
Chiu HI; Wu SB; Tsai CC
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542262
[TBL] [Abstract][Full Text] [Related]
31. Serological reactivity of recombinant 1D autoantigen and its expression in human thyroid and eye muscle tissue: a possible autoantigenic link in Graves' patients.
Kromminga A; Hagel C; Arndt R; Schuppert F
J Clin Endocrinol Metab; 1998 Aug; 83(8):2817-23. PubMed ID: 9709953
[TBL] [Abstract][Full Text] [Related]
32. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
33. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to orbital tissues in thyroid-associated ophthalmopathy.
Perros P; Kendall-Taylor P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):137-42. PubMed ID: 1543019
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
[TBL] [Abstract][Full Text] [Related]
36. A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
Diana T; Ungerer M; Wüster C; Faßbender J; Li Z; Reimann A; Holthoff HP; Kanitz M; Kahaly GJ
J Autoimmun; 2021 Aug; 122():102666. PubMed ID: 34144327
[TBL] [Abstract][Full Text] [Related]
37. Biological activity of autoantibodies from patients with thyroid-associated ophthalmopathy: in vitro effects on porcine extraocular myoblasts.
Perros P; Kendall-Taylor P
Q J Med; 1992 Sep; 84(305):691-706. PubMed ID: 1480743
[TBL] [Abstract][Full Text] [Related]
38. Relationship between smoking and serum levels of eye muscle and orbital connective tissue antibodies in patients with Graves ophthalmopathy.
Lahooti H; Champion B; Wall JR
Endocrine; 2023 Mar; ():. PubMed ID: 36905575
[TBL] [Abstract][Full Text] [Related]
39. IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy.
Shi L; Ye H; Huang J; Li Y; Wang X; Xu Z; Chen J; Xiao W; Chen R; Yang H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3125-e3142. PubMed ID: 33693700
[TBL] [Abstract][Full Text] [Related]
40. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
Smith TJ; Tsai CC; Shih MJ; Tsui S; Chen B; Han R; Naik V; King CS; Press C; Kamat S; Goldberg RA; Phipps RP; Douglas RS; Gianoukakis AG
Thyroid; 2008 Sep; 18(9):983-8. PubMed ID: 18788919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
